Daily news on nutraceuticals, functional foods, health food and ingredients in Asia and Oceania.

Headlines

Due to uncertainties posed by COVID-19, China's plant extract companies are cautious in making new investments to ramp up their production capability although demand has increased. © Getty Images

COVID-19 caution: Chinese botanical suppliers hold back on capacity building despite demand spike

Plant extract companies in China are seeing more demand for immune-related raw materials, but most are adopting a cautious stance when it comes to capacity building due to trade uncertainties brought on by COVID-19.

NutraIngredients-Asia Awards: Clock ticking to enter 2020 awards...check out last year's winners

There are three weeks left to submit entries for the 2020 NutraIngredients-Asia Awards and stand a chance to be crowned among the region's brightest and best, and take your place on the roll of honour alongside our victorious companies from 2019.

Content provided by TSI Group Ltd

Joint Decisions: Why the Right Glucosamine Partner Makes a Difference

Joint health formulas remain a competitive consumer product sector, as multiple millions of aging people demand them. Here’s why the right partner helps your product stand out.

Less wine waste: Swisse to launch products containing upcycled grape seed extract in 2021

Health and wellness powerhouse Swisse plans to roll out dietary supplements and skincare products containing upcycled grape seed extract derived from Australia’s wine-producing industry.

GALLERY: The 10 most read APAC health and nutrition stories in May

See May's 10 most read stories, including COVID-19's clinical trials research and what firms have done to cope with disruptions caused by the pandemic.

Bright future: VitaHealth eyes growing opportunity with vision care supplements as screen time soars

VitaHealth is tapping into growing demand among Singapore’s myopic population to push sales of its eye health supplements, with screen use increasing as more people work from home and join virtual meetings due to the COVID-19 pandemic.

Triple target: China, Indonesia and India key for Blackmores' growth as firm taps investors for regional expansion

Australian supplements giant Blackmores is tapping investors for AUD117m (US$78m) to help drive its expansion in Asia – although the firm’s largest shareholder Marcus Blackmore won’t be among those dipping into his pocket.